Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Lymphoma

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 63 articles:
HTML format



Single Articles


    April 2024
  1. HASAN I, Parsons L, Duran S, Zinn Z, et al
    Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.
    J Am Acad Dermatol. 2024 Apr 6:S0190-9622(24)00566.
    PubMed     Abstract available


  2. POWERS CM, Piontkowski AJ, Orloff J, Pulsinelli J, et al
    Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database.
    J Am Acad Dermatol. 2024 Apr 4:S0190-9622(24)00554.
    PubMed    


    March 2024
  3. BANNER L, Rohan TZ, Zachian R, Gross T, et al
    Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
    PubMed    


  4. CHEN J, Martinez A, Shinohara MM
    Risk of Systemic Lymphoma in Patients with Cutaneous CD30+ Lymphoproliferative Disorders: A Single Center Retrospective Cohort Analysis.
    J Am Acad Dermatol. 2024 Mar 13:S0190-9622(24)00489.
    PubMed    


  5. DIAZ MJ, Haq Z, Tran JT, Abdi P, et al
    Psoriasis and non-Hodgkin's lymphoma in a diverse sample of U.S. adults: a propensity matched case-control study.
    J Am Acad Dermatol. 2024 Mar 5:S0190-9622(24)00440.
    PubMed    


    February 2024
  6. OLSEN EA, Hodak E, Geskin L, Scarisbrick J, et al
    Bridging the specialty gap: Update on primary cutaneous lymphomas.
    J Am Acad Dermatol. 2024;90:257-260.
    PubMed    


  7. HOOPER MJ, Veon FL, Enriquez GL, Nguyen M, et al
    Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL.
    J Am Acad Dermatol. 2024;90:e79.
    PubMed    


    January 2024
  8. PATTERSON A
    JAAD Game Changer: "Early clinical manifestations of Sezary syndrome: A multicenter retrospective cohort study".
    J Am Acad Dermatol. 2024;90:121.
    PubMed    


    December 2023
  9. NOCCO SE, Ewalt MD, Moy AP, Lewis NE, et al
    TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: a retrospective analysis of 39 cases.
    J Am Acad Dermatol. 2023 Dec 5:S0190-9622(23)03269.
    PubMed    


    October 2023
  10. WU Y, Kang K, Sun X, Niu T, et al
    Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02886.
    PubMed    


    September 2023
  11. XIANG DH, Perlman KL, Brumbaugh B, Reardon RM, et al
    Prevalence of Autoimmune Diseases in Cutaneous B-Cell Lymphoma: A Retrospective Cross Sectional Analysis.
    J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02829.
    PubMed    


    July 2023
  12. LEWITT TM, Walker CJ, Espinosa ML, Chung C, et al
    Reply to letter to the editor (Manuscript # JAAD-D-22-03011R1).
    J Am Acad Dermatol. 2023;89:e67.
    PubMed    


  13. LITAIEM N, Fazzani M, Zeglaoui F
    A need for a clear definition of mycosis fungoides flares to evaluate disease course during pregnancy.
    J Am Acad Dermatol. 2023;89:e65-e66.
    PubMed    


    June 2023
  14. JOSHI TP, Duvic M
    Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.
    J Am Acad Dermatol. 2023;88:e305-e306.
    PubMed    


    May 2023
  15. ARCURI D, Kaouache M, Lagace F, Sasseville D, et al
    Research Letter: A Case-Control Pharmacovigilance Study of TNF-Alpha Inhibitors and Interleukin Inhibitors on Tuberculosis, Candida, Lymphoma and Suicidality Using the FAERS Database (2014-2020).
    J Am Acad Dermatol. 2023 May 26:S0190-9622(23)00980.
    PubMed    


  16. JFRI A, Smith JS, Larocca C
    Diagnosis of mycosis fungoides or Sezary syndrome after dupilumab use: A systematic review.
    J Am Acad Dermatol. 2023;88:1164-1166.
    PubMed    


  17. PLAZA JA, Gru AA, Sangueza OP, Lourenco SV, et al
    An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I.
    J Am Acad Dermatol. 2023;88:965-980.
    PubMed     Abstract available


    April 2023
  18. GESKIN LJ, Kwinta BD, Garcia-Saleem TJ, Akilov OE, et al
    International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
    J Am Acad Dermatol. 2023;88:935-937.
    PubMed    


    March 2023
  19. BAYKAL C, Atci T
    Clinical features and staging of mycosis fungoides of the eyelids: A retrospective cohort study.
    J Am Acad Dermatol. 2023;88:729-731.
    PubMed    


  20. JOSHI TP, Black TA, Fernandez B, Friske S, et al
    Comorbidities associated with mycosis fungoides: A case-control study in the All of Us database.
    J Am Acad Dermatol. 2023;88:686-688.
    PubMed    


    January 2023
  21. JACOB JS, Hunt RD
    Increasing incidence of pediatric mycosis fungoides from 2000 to 2017: A national population-based study of the Surveillance, Epidemiology, and End Results database and Texas Cancer Registry.
    J Am Acad Dermatol. 2023;88:185-187.
    PubMed    


    December 2022
  22. COHEN JM, Damsky W, Girardi M
    Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab".
    J Am Acad Dermatol. 2022;87:e241-e242.
    PubMed    


  23. MCKENZIE S, Brown-Korsah JB, Syder NC, Omar D, et al
    Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color.
    J Am Acad Dermatol. 2022;87:1261-1270.
    PubMed     Abstract available


    November 2022
  24. CHUNG C, Espinosa ML, Walker CJ, Choi J, et al
    Acceleration of skin involvement may predict disease progression in early-stage mycosis fungoides: A retrospective cohort study.
    J Am Acad Dermatol. 2022;87:1140-1141.
    PubMed    


    October 2022
  25. HOOPER MJ, Veon FL, Enriquez GL, Nguyen M, et al
    Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk for Black patients.
    J Am Acad Dermatol. 2022 Oct 17. pii: S0190-9622(22)02900.
    PubMed     Abstract available


  26. HEYMANN WR
    Differentiating hyperkeratotic palmoplantar dermatoses: Give your dermatopathologist a hand.
    J Am Acad Dermatol. 2022;87:752-753.
    PubMed    


  27. BOZON A, Avinens O, Lacheretz-Szablewski V, Dereure O, et al
    Spatial and temporal homogeneity of T-cell receptor gamma chain rearrangements in mycosis fungoides: A next-generation sequencing analysis.
    J Am Acad Dermatol. 2022;87:908-910.
    PubMed    


  28. BUECHLER CR, Sagher E, Tisack A, Jacobsen G, et al
    Contribution of socioeconomic risk factors within a diverse mycosis fungoides cohort from Detroit, Michigan.
    J Am Acad Dermatol. 2022;87:897-900.
    PubMed    


  29. KIM SR, McNiff JM, Ko CJ
    Clustered intraepidermal lymphocytes and Langerhans cell microgranulomas are consistently observed in hyperkeratotic palmoplantar eczema compared with palmoplantar psoriasis and mycosis fungoides palmaris et plantaris.
    J Am Acad Dermatol. 2022;87:884-886.
    PubMed    


    September 2022
  30. KIM SR, Ko CJ, Nelson CA, Ramachandran S, et al
    Random skin biopsies for diagnosis of intravascular large B cell lymphoma: retrospective analysis of 31 biopsies from a US dermatology inpatient consultative service with literature review.
    J Am Acad Dermatol. 2022 Sep 21. pii: S0190-9622(22)02740.
    PubMed    


    July 2022
  31. HIMELES JR, Holton J, Vittorio C, Rook AH, et al
    Paying the Price of Cutaneous T-cell Lymphoma: An analysis of recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma.
    J Am Acad Dermatol. 2022 Jul 18. pii: S0190-9622(22)02251.
    PubMed    


  32. QUERFELD C, Kim YH, Guitart J, Scarisbrick J, et al
    Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study.
    J Am Acad Dermatol. 2022;87:209-211.
    PubMed    


    June 2022
  33. O'DONNELL M, Zaya R, Correia E, Krishnasamy S, et al
    Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
    J Am Acad Dermatol. 2022;86:1285-1292.
    PubMed     Abstract available


  34. SUH KS, Jang MS, Jung JH, Kwon DI, et al
    Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review.
    J Am Acad Dermatol. 2022;86:1275-1284.
    PubMed     Abstract available


  35. CHOI J, Sutaria N, Roh YS, Bordeaux Z, et al
    Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample.
    J Am Acad Dermatol. 2022;86:1408-1410.
    PubMed    


  36. JUNG JM, Yoo H, Lim DJ, Won CH, et al
    Clinicoprognostic implications of head and neck involvement by mycosis fungoides: A retrospective cohort study.
    J Am Acad Dermatol. 2022;86:1258-1265.
    PubMed     Abstract available


    May 2022
  37. BESCH-STOKES JG, Costello CM, Severson KJ, Bhullar P, et al
    Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder: Diagnosis and management.
    J Am Acad Dermatol. 2022;86:1167-1169.
    PubMed    


    April 2022
  38. CHERAGHLOU S, Ugwu N, Girardi M
    Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma.
    J Am Acad Dermatol. 2022 Apr 24. pii: S0190-9622(22)00698.
    PubMed    


  39. ERRICHETTI E, Geller S, Zalaudek I, Longo C, et al
    Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas: A retrospective comparative study with pseudolymphomas and tumoral/inflammatory mimickers by the International Dermoscopy Society.
    J Am Acad Dermatol. 2022;86:774-781.
    PubMed     Abstract available


  40. NAWAR T, Elsayad K, Muller EC, Rolf D, et al
    Quality of life in patients with mycosis fungoides and Sezary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapy.
    J Am Acad Dermatol. 2022;86:889-891.
    PubMed    


  41. CARITI C, Quaglino P, Lupia T, Novelli M, et al
    Infections in Sezary syndrome: A retrospective cohort study of 113 patients.
    J Am Acad Dermatol. 2022;86:943-946.
    PubMed    


    March 2022
  42. MAGHFOUR J, Gill F, Olson J, Guido N, et al
    Association of Airborne Toxins with Geographic Clustering of Cutaneous T Cell Lymphoma in Louisiana.
    J Am Acad Dermatol. 2022 Mar 7. pii: S0190-9622(22)00378.
    PubMed    


    January 2022
  43. ABRAHAM J, Wei G, Desai SR, Seminario-Vidal L, et al
    A cross-sectional analysis of quality-of-life in skin of color patients with cutaneous t-cell lymphoma: an exploratory study.
    J Am Acad Dermatol. 2022 Jan 24. pii: S0190-9622(22)00100.
    PubMed    


  44. BELLINATO F, Gisondi P, Girolomoni G
    Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis.
    J Am Acad Dermatol. 2022;86:86-96.
    PubMed     Abstract available


  45. BEHBAHANI S, Yeh CJ, Fernandez JM, Chen ST, et al
    Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides.
    J Am Acad Dermatol. 2022;86:174-177.
    PubMed    


    December 2021
  46. ROLF D, Elsayad K, Eich HT
    Ultra-hypofractionated low-dose total skin electron beam followed by maintenance therapy: Preliminary findings from a prospective open-label study.
    J Am Acad Dermatol. 2021;85:1601-1603.
    PubMed    


    November 2021
  47. FERRIER A, Soong L, Alabdulsalam A, Kunimoto B, et al
    Diagnosis of gamma/delta mycosis fungoides requires longitudinal clinical observation.
    J Am Acad Dermatol. 2021;85:1352-1353.
    PubMed    


  48. GOYAL N, O'Leary D, Rubin N, Bohjanen K, et al
    Localization patterns and survival of extranodal natural killer/T-cell lymphomas in the United States: A population-based study of 945 cases.
    J Am Acad Dermatol. 2021;85:1318-1321.
    PubMed    


  49. OH Y, Stoll JR, Moskowitz A, Pulitzer M, et al
    Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part II: Prognosis and management.
    J Am Acad Dermatol. 2021;85:1093-1106.
    PubMed     Abstract available


  50. STOLL JR, Willner J, Oh Y, Pulitzer M, et al
    Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part I: Clinical and histologic features and diagnosis.
    J Am Acad Dermatol. 2021;85:1073-1090.
    PubMed     Abstract available


    October 2021
  51. LEWITT TM, Walker CJ, Espinosa ML, Chung C, et al
    Cutaneous T-Cell Lymphoma and Pregnancy: Great Uncertainty and an Appeal for Prospective Clinical Research.
    J Am Acad Dermatol. 2021 Oct 29. pii: S0190-9622(21)02725.
    PubMed    


  52. SEVERSON KJ, Cumsky HJL, Brumfiel CM, Janeczek MC, et al
    Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
    J Am Acad Dermatol. 2021;85:969-971.
    PubMed    


  53. KURAITIS D, McBurney E, Boh E
    Utility of clonal T-cell rearrangement study in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2021;85:1040-1042.
    PubMed    


    September 2021
  54. ROZENBAUM D, Tung J, Xue Y, Hoang MP, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: A retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2021;85:665-670.
    PubMed     Abstract available


  55. XUE R, Elbendary A, Liu H, Chen Y, et al
    Hydroa vacciniforme-like lymphoma: Clinicopathologic description, treatment, and outcome.
    J Am Acad Dermatol. 2021;85:752-755.
    PubMed    


    August 2021
  56. SAMIE FH
    JAAD Game Changers *: Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
    J Am Acad Dermatol. 2021;85:537.
    PubMed    


    July 2021
  57. GOYAL A, O'Leary D, Foreman RK, Duncan LM, et al
    Assessing the diagnosis of "primary cutaneous mantle cell lymphoma": A systematic review and population-based analysis.
    J Am Acad Dermatol. 2021 Jul 31. pii: S0190-9622(21)02201.
    PubMed    


  58. TUNG JK, Rozenbaum D, Rrapi R, Chand S, et al
    Skin biopsy in the diagnosis of intravascular lymphoma: a retrospective diagnostic accuracy study.
    J Am Acad Dermatol. 2021 Jul 24. pii: S0190-9622(21)02168.
    PubMed    


  59. ENZAN N, Kitadate A, Kono M
    Comment on skin biopsies for diagnosing intravascular lymphoma: a retrospective study of diagnostic accuracy.
    J Am Acad Dermatol. 2021 Jul 23. pii: S0190-9622(21)02167.
    PubMed    


  60. NEWMAN NB, Patel CG, Ding GX, Zic JA, et al
    Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique.
    J Am Acad Dermatol. 2021;85:121-127.
    PubMed     Abstract available


    March 2021
  61. KARTAN S, Shalabi D, O'Donnell M, Alpdogan SO, et al
    Response to topical corticosteroid monotherapy in mycosis fungoides.
    J Am Acad Dermatol. 2021;84:615-623.
    PubMed     Abstract available


    December 2020
  62. RAMACHANDRAN V, Park KE, Loya A, Duvic M, et al
    Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: A national database study.
    J Am Acad Dermatol. 2020;83:1786-1789.
    PubMed    


    November 2020
  63. SCHACHTER O, Tabibian-Keissar H, Debby A, Segal O, et al
    Evaluation of the polymerase chain reaction-based T-cell receptor beta clonality test in the diagnosis of early mycosis fungoides.
    J Am Acad Dermatol. 2020;83:1400-1405.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.